AFR lose some credibility over biotech stock analysis. It was only a couple of months back they referred to Mesoblast as 'serial disappointers' and 'serial capital raisers'. And not for the first time either. Rarely gave us a break.
Ryoncil: ODAC/FDA Meeting Discussion, page-1882
-
- There are more pages in this discussion • 165 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.030(2.52%) |
Mkt cap ! $1.324B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $4.738M | 4.022M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 96659 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 116483 | 14 |
View Market Depth
| Last trade - 14.57pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |